| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.924 | 0.001 | 0.924 | Immunostimulant | 0.676 0.009 DBMET01886 0.899 0.002 DBMET01885 0.676 0.009 DBMET01887 | ||
| 0.909 | 0.001 | 0.909 | Neuropeptide Y2 antagonist | 0.305 0.017 DBMET01886 0.76 0.003 DBMET01885 0.305 0.017 DBMET01887 | ||
| 0.803 | 0.004 | 0.803 | Antiamyloidogenic | 0.399 0.029 DBMET01886 0.687 0.005 DBMET01885 0.399 0.029 DBMET01887 | ||
| 0.727 | 0.004 | 0.727 | Interleukin antagonist | 0.621 0.01 DBMET01886 0.686 0.005 DBMET01885 0.621 0.01 DBMET01887 | ||
| 0.696 | 0.003 | 0.79 | Insulysin inhibitor | 0.482 0.011 DBMET01886 0.79 0.002 DBMET01885 0.482 0.011 DBMET01887 | DBMET01885 | |
| 0.605 | 0.006 | 0.605 | Angiogenesis stimulant | 0.548 0.009 DBMET01886 0.602 0.007 DBMET01885 0.548 0.009 DBMET01887 | ||
| 0.599 | 0.004 | 0.599 | Growth hormone agonist | 0.487 0.007 DBMET01886 0.515 0.005 DBMET01885 0.487 0.007 DBMET01887 | ||
| 0.587 | 0 | 0.587 | Bombesin 2 receptor antagonist | 0.265 0.004 DBMET01886 0.516 0 DBMET01885 0.265 0.004 DBMET01887 | ||
| 0.585 | 0.003 | 0.585 | Glucagon-like peptide 1 agonist | 0.129 0.012 DBMET01886 0.196 0.004 DBMET01885 0.129 0.012 DBMET01887 | ||
| 0.522 | 0.003 | 0.573 | Neurotensin receptor agonist | 0.389 0.007 DBMET01886 0.573 0.001 DBMET01885 0.389 0.007 DBMET01887 | DBMET01885 | |
| 0.489 | 0.004 | 0.489 | Proteasome inhibitor | 0.176 0.034 DBMET01886 0.465 0.004 DBMET01885 0.176 0.034 DBMET01887 | ||
| 0.463 | 0.006 | 0.544 | Thrombolytic | 0.486 0.005 DBMET01886 0.544 0.005 DBMET01885 0.486 0.005 DBMET01887 | DBMET01885 | |
| 0.476 | 0.024 | 0.497 | Apoptosis antagonist | 0.408 0.036 DBMET01886 0.497 0.021 DBMET01885 0.408 0.036 DBMET01887 | DBMET01885 | |
| 0.449 | 0.002 | 0.449 | Ribonucleotide reductase inhibitor | 0.128 0.015 DBMET01886 0.241 0.005 DBMET01885 0.128 0.015 DBMET01887 | ||
| 0.446 | 0.002 | 0.446 | Ribonucleoside-diphosphate reductase inhibitor | 0.125 0.015 DBMET01886 0.24 0.005 DBMET01885 0.125 0.015 DBMET01887 | ||
| 0.43 | 0.022 | 0.578 | Platelet antagonist | 0.578 0.008 DBMET01886 0.528 0.011 DBMET01885 0.578 0.008 DBMET01887 | DBMET01887 | |
| 0.433 | 0.035 | 0.563 | Immunomodulator | 0.563 0.015 DBMET01886 0.417 0.039 DBMET01885 0.563 0.015 DBMET01887 | DBMET01887 | |
| 0.387 | 0.014 | 0.667 | Thiol protease inhibitor | 0.235 0.03 DBMET01886 0.667 0.005 DBMET01885 0.235 0.03 DBMET01887 | DBMET01885 | |
| 0.374 | 0.001 | 0.534 | Toll-Like receptor 2 agonist | 0.372 0.001 DBMET01886 0.534 0.001 DBMET01885 0.372 0.001 DBMET01887 | DBMET01885 | |
| 0.38 | 0.012 | 0.477 | Calpain inhibitor | 0.329 0.021 DBMET01886 0.477 0.004 DBMET01885 0.329 0.021 DBMET01887 | DBMET01885 | |
| 0.393 | 0.051 | 0.662 | Antithrombotic | 0.583 0.018 DBMET01886 0.662 0.01 DBMET01885 0.583 0.018 DBMET01887 | DBMET01885 | |
| 0.376 | 0.035 | 0.473 | Interleukin 2 agonist | 0.473 0.012 DBMET01886 0.429 0.02 DBMET01885 0.473 0.012 DBMET01887 | DBMET01887 | |
| 0.361 | 0.02 | 0.466 | Anticoagulant | 0.372 0.019 DBMET01886 0.466 0.012 DBMET01885 0.372 0.019 DBMET01887 | DBMET01885 | |
| 0.34 | 0.01 | 0.34 | Adenylate cyclase inhibitor | 0.208 0.024 DBMET01886 0.32 0.012 DBMET01885 0.208 0.024 DBMET01887 | ||
| 0.32 | 0.003 | 0.32 | Neuropeptide agonist | 0.094 0.028 DBMET01886 0.171 0.008 DBMET01885 0.094 0.028 DBMET01887 | ||
| 0.328 | 0.04 | 0.358 | Amyloid beta aggregation inhibitor | 0.328 0.04 DBMET01886 0.358 0.033 DBMET01885 0.328 0.04 DBMET01887 | DBMET01885 | |
| 0.281 | 0.003 | 0.281 | Bombesin 1 receptor agonist | 0.062 0.038 DBMET01886 0.173 0.006 DBMET01885 0.062 0.038 DBMET01887 | ||
| 0.284 | 0.01 | 0.284 | Histone deacetylase SIRT1 inhibitor | 0.27 0.013 DBMET01886 0.264 0.014 DBMET01885 0.27 0.013 DBMET01887 | ||
| 0.301 | 0.034 | 0.363 | Platelet adhesion inhibitor | 0.363 0.017 DBMET01886 0.338 0.023 DBMET01885 0.363 0.017 DBMET01887 | DBMET01887 | |
| 0.264 | 0 | 0.264 | Calcitonin receptor agonist | 0.136 0.005 DBMET01886 0.182 0.001 DBMET01885 0.136 0.005 DBMET01887 | ||
| 0.265 | 0.008 | 0.265 | Histone deacetylase class III inhibitor | 0.208 0.017 DBMET01886 0.237 0.011 DBMET01885 0.208 0.017 DBMET01887 | ||
| 0.26 | 0.023 | 0.277 | Bone formation stimulant | 0.236 0.028 DBMET01886 0.277 0.02 DBMET01885 0.236 0.028 DBMET01887 | DBMET01885 | |
| 0.237 | 0.006 | 0.416 | Carbonic anhydrase stimulant | 0.229 0.006 DBMET01886 0.416 0.003 DBMET01885 0.229 0.006 DBMET01887 | DBMET01885 | |
| 0.232 | 0.011 | 0.238 | Neuropeptide Y1 antagonist | 0.15 0.065 DBMET01886 0.238 0.01 DBMET01885 0.15 0.065 DBMET01887 | DBMET01885 | |
| 0.226 | 0.004 | 0.444 | Cholecystokinin B agonist | 0.444 0.003 DBMET01886 0.376 0.003 DBMET01885 0.444 0.003 DBMET01887 | DBMET01887 | |
| 0.221 | 0.003 | 0.221 | Bombesin antagonist | 0.06 0.018 DBMET01886 0.169 0.004 DBMET01885 0.06 0.018 DBMET01887 | ||
| 0.229 | 0.013 | 0.233 | Nav1.4 sodium channel blocker | 0.159 0.03 DBMET01886 0.233 0.012 DBMET01885 0.159 0.03 DBMET01887 | DBMET01885 | |
| 0.216 | 0.01 | 0.221 | Selectin antagonist | 0.2 0.011 DBMET01886 0.221 0.009 DBMET01885 0.2 0.011 DBMET01887 | DBMET01885 | |
| 0.214 | 0.009 | 0.266 | Hematopoietic | 0.266 0.006 DBMET01886 0.18 0.012 DBMET01885 0.266 0.006 DBMET01887 | DBMET01887 | |
| 0.195 | 0.004 | 0.195 | Glucagon-like peptide 1 receptor antagonist | 0.057 0.009 DBMET01886 0.062 0.008 DBMET01885 0.057 0.009 DBMET01887 | ||
| 0.201 | 0.011 | 0.201 | Opioid delta receptor antagonist | 0.082 0.035 DBMET01886 0.167 0.016 DBMET01885 0.082 0.035 DBMET01887 | ||
| 0.201 | 0.014 | 0.201 | Opioid antagonist | 0.09 0.057 DBMET01886 0.168 0.021 DBMET01885 0.09 0.057 DBMET01887 | ||
| 0.189 | 0.007 | 0.189 | Melanocortin 1 antagonist | 0.033 0.032 DBMET01886 0.121 0.009 DBMET01885 0.033 0.032 DBMET01887 | ||
| 0.238 | 0.06 | 0.304 | Peptidyltransferase inhibitor | 0.304 0.023 DBMET01886 0.207 0.091 DBMET01885 0.304 0.023 DBMET01887 | DBMET01887 | |
| 0.296 | 0.118 | 0.375 | Immunosuppressant | 0.375 0.074 DBMET01886 0.323 0.101 DBMET01885 0.375 0.074 DBMET01887 | DBMET01887 | |
| 0.198 | 0.022 | 0.553 | Aminopeptidase B inhibitor | 0.553 0.003 DBMET01886 0.536 0.003 DBMET01885 0.553 0.003 DBMET01887 | DBMET01887 | |
| 0.19 | 0.017 | 0.201 | Protease inhibitor | 0.143 0.033 DBMET01886 0.201 0.014 DBMET01885 0.143 0.033 DBMET01887 | DBMET01885 | |
| 0.273 | 0.105 | 0.375 | Sodium/bile acid cotransporter inhibitor | 0.375 0.026 DBMET01886 0.338 0.048 DBMET01885 0.375 0.026 DBMET01887 | DBMET01887 | |
| 0.172 | 0.01 | 0.185 | Factor V inhibitor | 0.18 0.009 DBMET01886 0.185 0.007 DBMET01885 0.18 0.009 DBMET01887 | DBMET01885 | |
| 0.167 | 0.014 | 0.167 | Opioid mu receptor antagonist | 0.066 0.049 DBMET01886 0.136 0.02 DBMET01885 0.066 0.049 DBMET01887 | ||
| 0.235 | 0.086 | 0.269 | Hypoglycemic | 0.269 0.066 DBMET01886 0.225 0.093 DBMET01885 0.269 0.066 DBMET01887 | DBMET01887 | |
| 0.178 | 0.03 | 0.365 | Cathepsin H inhibitor | 0.232 0.016 DBMET01886 0.365 0.007 DBMET01885 0.232 0.016 DBMET01887 | DBMET01885 | |
| 0.149 | 0.004 | 0.149 | Gonadotropin-releasing hormone receptor agonist | 0.066 0.031 DBMET01886 0.123 0.006 DBMET01885 0.066 0.031 DBMET01887 | ||
| 0.139 | 0.009 | 0.139 | Sirtuin 1 inhibitor | 0.134 0.01 DBMET01886 0.108 0.019 DBMET01885 0.134 0.01 DBMET01887 | ||
| 0.123 | 0.005 | 0.123 | Growth hormone secretagogue receptor antagonist | 0.061 0.013 DBMET01885 | ||
| 0.158 | 0.047 | 0.628 | Toll-Like receptor 2 antagonist | 0.628 0.002 DBMET01886 0.351 0.004 DBMET01885 0.628 0.002 DBMET01887 | DBMET01887 | |
| 0.13 | 0.019 | 0.13 | Somatostatin 1 agonist | 0.074 0.058 DBMET01886 0.122 0.023 DBMET01885 0.074 0.058 DBMET01887 | ||
| 0.161 | 0.05 | 0.195 | Neurotrophic factor | 0.13 0.081 DBMET01886 0.195 0.03 DBMET01885 0.13 0.081 DBMET01887 | DBMET01885 | |
| 0.204 | 0.094 | 0.223 | Free radical scavenger | 0.223 0.081 DBMET01886 0.202 0.096 DBMET01885 0.223 0.081 DBMET01887 | DBMET01887 | |
| 0.122 | 0.012 | 0.257 | Neurotensin receptor antagonist | 0.102 0.014 DBMET01886 0.257 0.005 DBMET01885 0.102 0.014 DBMET01887 | DBMET01885 | |
| 0.118 | 0.009 | 0.118 | Cathepsin E inhibitor | 0.068 0.031 DBMET01886 0.11 0.011 DBMET01885 0.068 0.031 DBMET01887 | ||
| 0.122 | 0.016 | 0.332 | Neutrophil collagenase inhibitor | 0.128 0.015 DBMET01886 0.332 0.004 DBMET01885 0.128 0.015 DBMET01887 | DBMET01885 | |
| 0.111 | 0.006 | 0.132 | Complement C3a chemotactic receptor antagonist | 0.132 0.004 DBMET01886 0.132 0.004 DBMET01885 0.132 0.004 DBMET01887 | DBMET01887 | |
| 0.121 | 0.019 | 0.121 | 3C-Like protease (SARS coronavirus) inhibitor | 0.109 0.026 DBMET01885 | ||
| 0.12 | 0.023 | 0.148 | Factor XII inhibitor | 0.097 0.04 DBMET01886 0.148 0.013 DBMET01885 0.097 0.04 DBMET01887 | DBMET01885 | |
| 0.106 | 0.01 | 0.106 | Bombesin 3 receptor antagonist | 0.069 0.025 DBMET01885 | ||
| 0.183 | 0.09 | 0.717 | Psychostimulant | 0.717 0.004 DBMET01886 0.273 0.051 DBMET01885 0.717 0.004 DBMET01887 | DBMET01887 | |
| 0.143 | 0.051 | 0.338 | Cell adhesion inhibitor | 0.338 0.008 DBMET01886 0.214 0.021 DBMET01885 0.338 0.008 DBMET01887 | DBMET01887 | |
| 0.106 | 0.017 | 0.122 | Cathepsin D inhibitor | 0.055 0.037 DBMET01886 0.122 0.012 DBMET01885 0.055 0.037 DBMET01887 | DBMET01885 | |
| 0.09 | 0.004 | 0.09 | Bombesin 1 receptor antagonist | 0.069 0.005 DBMET01885 | ||
| 0.18 | 0.096 | 0.328 | Insulin sensitizer | 0.328 0.011 DBMET01886 0.281 0.021 DBMET01885 0.328 0.011 DBMET01887 | DBMET01887 | |
| 0.088 | 0.009 | 0.088 | Melanocortin 1 agonist | 0.076 0.01 DBMET01885 | ||
| 0.084 | 0.005 | 0.084 | Growth hormone releasing factor agonist | 0.034 0.023 DBMET01885 | ||
| 0.09 | 0.012 | 0.095 | Melanocortin 3 antagonist | 0.095 0.012 DBMET01885 | DBMET01885 | |
| 0.082 | 0.006 | 0.082 | GHS receptor agonist | 0.045 0.025 DBMET01885 | ||
| 0.147 | 0.071 | 0.26 | Hemostatic | 0.183 0.04 DBMET01886 0.26 0.02 DBMET01885 0.183 0.04 DBMET01887 | DBMET01885 | |
| 0.084 | 0.012 | 0.095 | Cholecystokinin A antagonist | 0.055 0.018 DBMET01886 0.095 0.009 DBMET01885 0.055 0.018 DBMET01887 | DBMET01885 | |
| 0.076 | 0.003 | 0.076 | Glucagon agonist | 0.034 0.005 DBMET01885 | ||
| 0.115 | 0.043 | 0.287 | Folate antagonist | 0.287 0.004 DBMET01886 0.165 0.017 DBMET01885 0.287 0.004 DBMET01887 | DBMET01887 | |
| 0.087 | 0.016 | 0.087 | Opioid mu receptor agonist | 0.045 0.034 DBMET01886 0.084 0.017 DBMET01885 0.045 0.034 DBMET01887 | ||
| 0.08 | 0.009 | 0.08 | Growth hormone release inhibitor | 0.042 0.029 DBMET01886 0.059 0.016 DBMET01885 0.042 0.029 DBMET01887 | ||
| 0.079 | 0.009 | 0.079 | Melanocortin 5 agonist | 0.047 0.012 DBMET01885 | ||
| 0.081 | 0.013 | 0.173 | Erythropoietin receptor agonist | 0.041 0.027 DBMET01886 0.173 0.007 DBMET01885 0.041 0.027 DBMET01887 | DBMET01885 | |
| 0.077 | 0.009 | 0.077 | Renin inhibitor | 0.036 0.026 DBMET01886 0.053 0.016 DBMET01885 0.036 0.026 DBMET01887 | ||
| 0.157 | 0.09 | 0.205 | Catenin beta inhibitor | 0.205 0.028 DBMET01886 0.173 0.062 DBMET01885 0.205 0.028 DBMET01887 | DBMET01887 | |
| 0.08 | 0.014 | 0.084 | Angiotensin-converting enzyme inhibitor | 0.079 0.014 DBMET01886 0.084 0.012 DBMET01885 0.079 0.014 DBMET01887 | DBMET01885 | |
| 0.105 | 0.04 | 0.171 | Aminoacyl-tRNA synthetase inhibitor | 0.171 0.014 DBMET01886 0.097 0.049 DBMET01885 0.171 0.014 DBMET01887 | DBMET01887 | |
| 0.085 | 0.02 | 0.091 | Caspase 9 inhibitor | 0.078 0.024 DBMET01886 0.091 0.017 DBMET01885 0.078 0.024 DBMET01887 | DBMET01885 | |
| 0.069 | 0.005 | 0.138 | Cholecystokinin agonist | 0.138 0.004 DBMET01886 0.124 0.004 DBMET01885 0.138 0.004 DBMET01887 | DBMET01887 | |
| 0.085 | 0.021 | 0.098 | Human rhinovirus A protease inhibitor | 0.065 0.031 DBMET01886 0.098 0.017 DBMET01885 0.065 0.031 DBMET01887 | DBMET01885 | |
| 0.077 | 0.014 | 0.077 | Melanocortin antagonist | 0.075 0.015 DBMET01885 | ||
| 0.081 | 0.019 | 0.081 | Opioid agonist | 0.067 0.025 DBMET01885 | ||
| 0.092 | 0.031 | 0.115 | Thrombin inhibitor | 0.083 0.039 DBMET01886 0.115 0.019 DBMET01885 0.083 0.039 DBMET01887 | DBMET01885 | |
| 0.073 | 0.013 | 0.093 | Cholecystokinin antagonist | 0.061 0.018 DBMET01886 0.093 0.009 DBMET01885 0.061 0.018 DBMET01887 | DBMET01885 | |
| 0.07 | 0.01 | 0.07 | Melanocortin agonist | 0.054 0.012 DBMET01885 | ||
| 0.093 | 0.035 | 0.1 | Analgesic, opioid | 0.075 0.054 DBMET01886 0.1 0.031 DBMET01885 0.075 0.054 DBMET01887 | DBMET01885 | |
| 0.072 | 0.014 | 0.075 | Melanocortin 4 antagonist | 0.038 0.034 DBMET01886 0.075 0.013 DBMET01885 0.038 0.034 DBMET01887 | DBMET01885 | |
| 0.092 | 0.035 | 0.092 | Histone deacetylase SIRT2 inhibitor | 0.072 0.053 DBMET01885 | ||
| 0.066 | 0.01 | 0.066 | Melanocortin 3 agonist | 0.053 0.011 DBMET01885 | ||
| 0.07 | 0.014 | 0.079 | Carbonic anhydrase II stimulant | 0.079 0.009 DBMET01886 0.073 0.012 DBMET01885 0.079 0.009 DBMET01887 | DBMET01887 | |
| 0.14 | 0.085 | 0.141 | Insulin secretagoues | 0.141 0.084 DBMET01886 0.119 0.112 DBMET01885 0.141 0.084 DBMET01887 | DBMET01887 | |
| 0.062 | 0.012 | 0.065 | Neurokinin 2 agonist | 0.057 0.014 DBMET01886 0.065 0.01 DBMET01885 0.057 0.014 DBMET01887 | DBMET01885 | |
| 0.06 | 0.012 | 0.062 | Carbonic anhydrase I stimulant | 0.062 0.011 DBMET01886 0.058 0.013 DBMET01885 0.062 0.011 DBMET01887 | DBMET01887 | |
| 0.111 | 0.063 | 0.287 | Chelator | 0.287 0.012 DBMET01886 0.114 0.059 DBMET01885 0.287 0.012 DBMET01887 | DBMET01887 | |
| 0.068 | 0.021 | 0.132 | Endothelin-converting enzyme inhibitor | 0.048 0.032 DBMET01886 0.132 0.011 DBMET01885 0.048 0.032 DBMET01887 | DBMET01885 | |
| 0.075 | 0.028 | 0.096 | Aminopeptidase microsomal inhibitor | 0.096 0.018 DBMET01886 0.094 0.019 DBMET01885 0.096 0.018 DBMET01887 | DBMET01887 | |
| 0.073 | 0.027 | 0.107 | Cathepsin B inhibitor | 0.053 0.043 DBMET01886 0.107 0.014 DBMET01885 0.053 0.043 DBMET01887 | DBMET01885 | |
| 0.069 | 0.025 | 0.178 | GP IIb/IIIa receptor antagonist | 0.178 0.008 DBMET01886 0.16 0.01 DBMET01885 0.178 0.008 DBMET01887 | DBMET01887 | |
| 0.089 | 0.045 | 0.116 | Chymotrypsin inhibitor | 0.078 0.056 DBMET01886 0.116 0.027 DBMET01885 0.078 0.056 DBMET01887 | DBMET01885 | |
| 0.178 | 0.134 | 0.236 | Antioxidant | 0.236 0.092 DBMET01886 0.175 0.137 DBMET01885 0.236 0.092 DBMET01887 | DBMET01887 | |
| 0.05 | 0.007 | 0.05 | Growth hormone releasing factor antagonist | 0.033 0.012 DBMET01885 | ||
| 0.057 | 0.015 | 0.062 | Gonadotropin-releasing hormone receptor antagonist | 0.062 0.013 DBMET01885 | DBMET01885 | |
| 0.072 | 0.032 | 0.093 | Trypsin inhibitor | 0.068 0.035 DBMET01886 0.093 0.02 DBMET01885 0.068 0.035 DBMET01887 | DBMET01885 | |
| 0.046 | 0.006 | 0.046 | Growth hormone release promoting | |||
| 0.065 | 0.025 | 0.129 | Protease activated receptor 1 antagonist | 0.129 0.009 DBMET01885 | DBMET01885 | |
| 0.07 | 0.033 | 0.106 | Nitric oxide donor | 0.106 0.006 DBMET01886 0.074 0.029 DBMET01885 0.106 0.006 DBMET01887 | DBMET01887 | |
| 0.047 | 0.011 | 0.057 | Cholecystokinin B antagonist | 0.038 0.016 DBMET01886 0.057 0.009 DBMET01885 0.038 0.016 DBMET01887 | DBMET01885 | |
| 0.045 | 0.009 | 0.045 | GHS receptor antagonist | |||
| 0.046 | 0.011 | 0.046 | Melanocortin 4 agonist | 0.038 0.013 DBMET01885 | ||
| 0.049 | 0.014 | 0.049 | Opioid delta receptor agonist | 0.043 0.017 DBMET01885 | ||
| 0.064 | 0.029 | 0.075 | Kallikrein 1 inhibitor | 0.075 0.02 DBMET01885 | DBMET01885 | |
| 0.049 | 0.015 | 0.049 | Somatostatin 2 antagonist | |||
| 0.052 | 0.019 | 0.052 | Somatostatin 1 antagonist | 0.039 0.027 DBMET01885 | ||
| 0.044 | 0.014 | 0.055 | Caspase 2 inhibitor | 0.055 0.01 DBMET01886 0.049 0.012 DBMET01885 0.055 0.01 DBMET01887 | DBMET01887 | |
| 0.05 | 0.021 | 0.05 | HIV-1 protease inhibitor | 0.047 0.024 DBMET01885 | ||
| 0.086 | 0.057 | 0.159 | Transcription factor NF kappa B stimulant | 0.159 0.014 DBMET01886 0.092 0.048 DBMET01885 0.159 0.014 DBMET01887 | DBMET01887 | |
| 0.04 | 0.012 | 0.049 | Bradykinin B2 receptor agonist | 0.045 0.01 DBMET01886 0.049 0.008 DBMET01885 0.045 0.01 DBMET01887 | DBMET01885 | |
| 0.032 | 0.005 | 0.127 | Cholecystokinin A agonist | 0.127 0.003 DBMET01886 0.107 0.004 DBMET01885 0.127 0.003 DBMET01887 | DBMET01887 | |
| 0.054 | 0.028 | 0.074 | Aminopeptidase N inhibitor | 0.074 0.019 DBMET01886 0.072 0.02 DBMET01885 0.074 0.019 DBMET01887 | DBMET01887 | |
| 0.03 | 0.005 | 0.03 | KiSS-1 receptor antagonist | 0.028 0.005 DBMET01885 | ||
| 0.062 | 0.037 | 0.076 | Plasminogen activator inhibitor | 0.076 0.028 DBMET01885 | DBMET01885 | |
| 0.082 | 0.058 | 0.391 | Glutathione S-transferase inhibitor | 0.391 0.002 DBMET01886 0.159 0.01 DBMET01885 0.391 0.002 DBMET01887 | DBMET01887 | |
| 0.043 | 0.019 | 0.043 | Nociceptin (N/OFQ) receptor antagonist | 0.035 0.025 DBMET01885 | ||
| 0.073 | 0.05 | 0.166 | Cathepsin G inhibitor | 0.08 0.044 DBMET01886 0.166 0.019 DBMET01885 0.08 0.044 DBMET01887 | DBMET01885 | |
| 0.069 | 0.048 | 0.07 | Elastase 1 inhibitor | 0.07 0.047 DBMET01885 | DBMET01885 | |
| 0.049 | 0.029 | 0.049 | Farnesyltransferase inhibitor | |||
| 0.062 | 0.042 | 0.062 | Corticotropin releasing factor 2 receptor antagonist | |||
| 0.043 | 0.025 | 0.062 | Integrin alpha5beta1 antagonist | 0.058 0.013 DBMET01886 0.062 0.011 DBMET01885 0.058 0.013 DBMET01887 | DBMET01885 | |
| 0.05 | 0.032 | 0.083 | Plasmin inhibitor | 0.083 0.021 DBMET01885 | DBMET01885 | |
| 0.027 | 0.008 | 0.064 | Protease activated receptor agonist | 0.064 0.004 DBMET01885 | DBMET01885 | |
| 0.037 | 0.019 | 0.038 | Growth factor receptor-bound protein 2 antagonist | 0.034 0.026 DBMET01886 0.038 0.018 DBMET01885 0.034 0.026 DBMET01887 | DBMET01885 | |
| 0.121 | 0.103 | 0.306 | Diuretic | 0.226 0.036 DBMET01886 0.306 0.021 DBMET01885 0.226 0.036 DBMET01887 | DBMET01885 | |
| 0.06 | 0.042 | 0.087 | CXC chemokine 4 receptor antagonist | 0.087 0.028 DBMET01885 | DBMET01885 | |
| 0.081 | 0.067 | 0.177 | Vanilloid agonist | 0.177 0.008 DBMET01886 0.112 0.023 DBMET01885 0.177 0.008 DBMET01887 | DBMET01887 | |
| 0.04 | 0.025 | 0.079 | Factor VIIa inhibitor | 0.079 0.014 DBMET01885 | DBMET01885 | |
| 0.034 | 0.02 | 0.052 | Carboxypeptidase B inhibitor | 0.051 0.006 DBMET01886 0.052 0.006 DBMET01885 0.051 0.006 DBMET01887 | DBMET01885 | |
| 0.077 | 0.063 | 0.085 | Opioid kappa receptor antagonist | 0.085 0.051 DBMET01885 | DBMET01885 | |
| 0.034 | 0.022 | 0.038 | Calpain 1 inhibitor | 0.032 0.028 DBMET01886 0.038 0.014 DBMET01885 0.032 0.028 DBMET01887 | DBMET01885 | |
| 0.023 | 0.013 | 0.023 | Human T-cell leukemia virus type I protease inhibitor | 0.022 0.013 DBMET01885 | ||
| 0.023 | 0.013 | 0.023 | Nociceptin (N/OFQ) receptor agonist | |||
| 0.014 | 0.004 | 0.014 | KiSS-1 receptor agonist | 0.013 0.004 DBMET01885 | ||
| 0.024 | 0.016 | 0.024 | Somatostatin 4 antagonist | |||
| 0.031 | 0.023 | 0.031 | Somatostatin agonist | |||
| 0.034 | 0.026 | 0.034 | Somatostatin 5 agonist | |||
| 0.044 | 0.036 | 0.062 | Urokinase inhibitor | 0.062 0.027 DBMET01885 | DBMET01885 | |
| 0.013 | 0.006 | 0.013 | Neurokinin 3 agonist | 0.011 0.008 DBMET01885 | ||
| 0.027 | 0.023 | 0.048 | Factor VII inhibitor | 0.048 0.012 DBMET01885 | DBMET01885 | |
| 0.019 | 0.015 | 0.029 | Neurokinin 1 agonist | 0.018 0.016 DBMET01886 0.029 0.01 DBMET01885 0.018 0.016 DBMET01887 | DBMET01885 | |
| 0.029 | 0.026 | 0.034 | Caspase 6 inhibitor | 0.032 0.018 DBMET01886 0.034 0.013 DBMET01885 0.032 0.018 DBMET01887 | DBMET01885 | |
| 0.032 | 0.03 | 0.038 | HCV polyprotein inhibitor | 0.038 0.014 DBMET01885 | DBMET01885 | |
| 0.14 | 0.142 | 0.305 | Platelet aggregation inhibitor | 0.305 0.035 DBMET01886 0.24 0.056 DBMET01885 0.305 0.035 DBMET01887 | DBMET01887 | |
| 0.017 | 0.019 | 0.027 | Neutral endopeptidase inhibitor | 0.027 0.013 DBMET01886 0.025 0.013 DBMET01885 0.027 0.013 DBMET01887 | DBMET01887 | |
| 0.026 | 0.028 | 0.029 | Vasopressin 1A agonist | 0.029 0.019 DBMET01885 | DBMET01885 | |
| 0.013 | 0.015 | 0.017 | Carbonic anhydrase IV stimulant | 0.014 0.012 DBMET01886 0.017 0.009 DBMET01885 0.014 0.012 DBMET01887 | DBMET01885 | |
| 0.057 | 0.061 | 0.07 | Neuraminidase (influenza) inhibitor | 0.07 0.035 DBMET01886 0.068 0.037 DBMET01885 0.07 0.035 DBMET01887 | DBMET01887 | |
| 0.044 | 0.048 | 0.058 | Collagenase inhibitor | 0.058 0.018 DBMET01885 | DBMET01885 | |
| 0.019 | 0.023 | 0.022 | Vasopressin 1 agonist | 0.022 0.015 DBMET01885 | DBMET01885 | |
| 0.031 | 0.036 | 0.15 | Integrin antagonist | 0.15 0.01 DBMET01886 0.085 0.019 DBMET01885 0.15 0.01 DBMET01887 | DBMET01887 | |
| 0.129 | 0.135 | 0.248 | Hepatoprotectant | 0.248 0.044 DBMET01886 0.154 0.106 DBMET01885 0.248 0.044 DBMET01887 | DBMET01887 | |
| 0.053 | 0.058 | 0.085 | Protease activated receptor antagonist | 0.085 0.02 DBMET01885 | DBMET01885 | |
| 0.102 | 0.108 | 0.125 | Nav1.2 sodium channel blocker | 0.125 0.078 DBMET01885 | DBMET01885 | |
| 0.156 | 0.162 | 0.715 | Interleukin agonist | 0.715 0.003 DBMET01886 0.386 0.021 DBMET01885 0.715 0.003 DBMET01887 | DBMET01887 | |
| 0.008 | 0.014 | 0.012 | Protease activated receptor 1 agonist | 0.012 0.008 DBMET01885 | DBMET01885 | |
| 0.024 | 0.031 | 0.039 | Plasmepsin I inhibitor | 0.039 0.013 DBMET01885 | DBMET01885 | |
| 0.021 | 0.029 | 0.034 | Bradykinin B2 receptor antagonist | 0.032 0.021 DBMET01886 0.034 0.021 DBMET01885 0.032 0.021 DBMET01887 | DBMET01885 | |
| 0.044 | 0.052 | 0.071 | Maillard reaction inhibitor | 0.071 0.029 DBMET01885 | DBMET01885 | |
| 0.024 | 0.033 | 0.038 | Trypsin I inhibitor | 0.038 0.019 DBMET01885 | DBMET01885 | |
| 0.023 | 0.032 | 0.029 | Antidiuretic hormone agonist | 0.029 0.016 DBMET01885 | DBMET01885 | |
| 0.037 | 0.049 | 0.049 | Kallikrein inhibitor | 0.049 0.03 DBMET01885 | DBMET01885 | |
| 0.125 | 0.137 | 0.153 | Interleukin 6 antagonist | 0.129 0.127 DBMET01886 0.153 0.084 DBMET01885 0.129 0.127 DBMET01887 | DBMET01885 | |
| 0.032 | 0.045 | 0.069 | Macrophage elastase inhibitor | 0.069 0.015 DBMET01886 0.053 0.022 DBMET01885 0.069 0.015 DBMET01887 | DBMET01887 | |
| 0.011 | 0.025 | 0.019 | Melatonin 3 antagonist | 0.019 0.013 DBMET01885 | DBMET01885 | |
| 0.007 | 0.025 | 0.145 | N-Acetylated alpha-linked acidic dipeptidase inhibitor | 0.145 0.003 DBMET01886 0.019 0.008 DBMET01885 0.145 0.003 DBMET01887 | DBMET01887 | |
| 0.065 | 0.083 | 0.239 | Cell adhesion molecule inhibitor | 0.239 0.007 DBMET01886 0.108 0.029 DBMET01885 0.239 0.007 DBMET01887 | DBMET01887 | |
| 0.07 | 0.089 | 0.159 | Falcipain inhibitor | 0.159 0.027 DBMET01885 | DBMET01885 | |
| 0.062 | 0.082 | 0.26 | Metalloproteinase-2 inhibitor | 0.124 0.028 DBMET01886 0.26 0.006 DBMET01885 0.124 0.028 DBMET01887 | DBMET01885 | |
| 0.053 | 0.077 | 0.074 | Histone deacetylase SIRT3 inhibitor | 0.074 0.023 DBMET01885 | DBMET01885 | |
| 0.02 | 0.044 | 0.027 | Complement C5a chemotactic receptor antagonist | 0.027 0.025 DBMET01885 | DBMET01885 | |
| 0.065 | 0.093 | 0.153 | Falcipain 2 inhibitor | 0.153 0.027 DBMET01885 | DBMET01885 | |
| 0.034 | 0.062 | 0.048 | Neuraminidase (Influenza A) inhibitor | 0.048 0.026 DBMET01886 0.046 0.03 DBMET01885 0.048 0.026 DBMET01887 | DBMET01887 | |
| 0.024 | 0.053 | 0.041 | Tryptase inhibitor | 0.038 0.025 DBMET01886 0.041 0.021 DBMET01885 0.038 0.025 DBMET01887 | DBMET01885 | |
| 0.011 | 0.04 | 0.056 | Vitronectin receptor antagonist | 0.056 0.006 DBMET01886 0.026 0.012 DBMET01885 0.056 0.006 DBMET01887 | DBMET01887 | |
| 0.013 | 0.044 | 0.043 | Integrin alphaVbeta3 antagonist | 0.043 0.005 DBMET01886 0.024 0.012 DBMET01885 0.043 0.005 DBMET01887 | DBMET01887 | |
| 0.037 | 0.071 | 0.047 | Baculoviral IAP repeat-containing protein inhibitor | 0.047 0.029 DBMET01885 | DBMET01885 | |
| 0.031 | 0.067 | 0.275 | Ornithine carbamoyltransferase inhibitor | 0.275 0.005 DBMET01886 0.055 0.035 DBMET01885 0.275 0.005 DBMET01887 | DBMET01887 | |
| 0.038 | 0.077 | 0.059 | Neuraminidase inhibitor | 0.059 0.044 DBMET01886 0.057 0.047 DBMET01885 0.059 0.044 DBMET01887 | DBMET01887 | |
| 0.009 | 0.048 | 0.035 | Integrin beta3 antagonist | 0.035 0.008 DBMET01886 0.035 0.008 DBMET01887 | DBMET01887 | |
| 0.003 | 0.045 | 0.01 | Carboxypeptidase B2 inhibitor | 0.01 0.009 DBMET01886 0.01 0.009 DBMET01887 | DBMET01887 | |
| 0.017 | 0.059 | 0.028 | Trypsin II inhibitor | 0.028 0.024 DBMET01885 | DBMET01885 | |
| 0.019 | 0.062 | 0.034 | Cathepsin L2 inhibitor | 0.034 0.033 DBMET01885 | DBMET01885 | |
| 0.003 | 0.048 | 0.01 | Phosphoribosylglycinamide formyltransferase inhibitor | 0.01 0.004 DBMET01886 0.01 0.004 DBMET01887 | DBMET01887 | |
| 0.135 | 0.181 | 0.349 | Vasodilator | 0.349 0.033 DBMET01886 0.153 0.152 DBMET01885 0.349 0.033 DBMET01887 | DBMET01887 | |
| 0.005 | 0.059 | 0.017 | Calcium-dependent phospholipase A2 inhibitor | 0.017 0.005 DBMET01886 0.017 0.005 DBMET01887 | DBMET01887 | |
| 0.082 | 0.145 | 0.14 | Lipid peroxidase inhibitor | 0.14 0.075 DBMET01886 0.14 0.075 DBMET01887 | DBMET01887 | |
| 0.02 | 0.084 | 0.07 | Oxytocin agonist | 0.068 0.011 DBMET01886 0.07 0.009 DBMET01885 0.068 0.011 DBMET01887 | DBMET01885 | |
| 0.006 | 0.071 | 0.028 | Integrin alpha4 antagonist | 0.028 0.017 DBMET01886 0.028 0.017 DBMET01887 | DBMET01887 | |
| 0.028 | 0.094 | 0.131 | Cathepsin L inhibitor | 0.131 0.016 DBMET01885 | DBMET01885 | |
| 0.009 | 0.078 | 0.022 | Integrin alphaVbeta1 antagonist | 0.022 0.01 DBMET01886 0.022 0.01 DBMET01887 | DBMET01887 | |
| 0.009 | 0.081 | 0.02 | Integrin beta5 antagonist | 0.02 0.015 DBMET01886 0.02 0.015 DBMET01887 | DBMET01887 | |
| 0.07 | 0.15 | 0.126 | Toll-Like receptor 4 antagonist | 0.126 0.038 DBMET01886 0.126 0.038 DBMET01887 | DBMET01887 | |
| 0.005 | 0.094 | 0.037 | Integrin alphaVbeta6 antagonist | 0.037 0.003 DBMET01886 0.016 0.008 DBMET01885 0.037 0.003 DBMET01887 | DBMET01887 | |
| 0.046 | 0.135 | 0.232 | Metalloproteinase-9 inhibitor | 0.098 0.033 DBMET01886 0.232 0.006 DBMET01885 0.098 0.033 DBMET01887 | DBMET01885 | |
| 0.016 | 0.106 | 0.034 | Baculoviral IAP repeat-containing protein 4 inhibitor | 0.028 0.018 DBMET01886 0.034 0.01 DBMET01885 0.028 0.018 DBMET01887 | DBMET01885 | |
| 0.025 | 0.14 | 0.186 | Matrix metalloproteinase (membrane-type) inhibitor | 0.091 0.016 DBMET01886 0.186 0.006 DBMET01885 0.091 0.016 DBMET01887 | DBMET01885 | |
| 0.003 | 0.126 | 0.032 | Aminopeptidase A inhibitor | 0.032 0.006 DBMET01886 0.016 0.015 DBMET01885 0.032 0.006 DBMET01887 | DBMET01887 | |
| 0.027 | 0.155 | 0.185 | Matrix metalloproteinase inhibitor | 0.093 0.03 DBMET01886 0.185 0.01 DBMET01885 0.093 0.03 DBMET01887 | DBMET01885 | |
| 0.016 | 0.146 | 0.027 | Toll-Like receptor 4 agonist | 0.027 0.017 DBMET01886 0.027 0.017 DBMET01887 | DBMET01887 | |
| 0.024 | 0.157 | 0.048 | VCAM-1 antagonist | 0.048 0.011 DBMET01886 0.048 0.011 DBMET01887 | DBMET01887 | |
| 0.024 | 0.158 | 0.048 | VCAM antagonist | 0.048 0.011 DBMET01886 0.048 0.011 DBMET01887 | DBMET01887 | |
| 0.006 | 0.141 | 0.041 | Sphingosine 1-phosphate receptor 3 agonist | 0.041 0.021 DBMET01886 0.041 0.021 DBMET01887 | DBMET01887 | |
| 0.015 | 0.155 | 0.173 | Metalloproteinase-3 inhibitor | 0.079 0.016 DBMET01886 0.173 0.004 DBMET01885 0.079 0.016 DBMET01887 | DBMET01885 | |
| 0.024 | 0.181 | 0.041 | Integrin alpha1beta1 antagonist | 0.041 0.019 DBMET01886 0.041 0.019 DBMET01887 | DBMET01887 | |
| 0.021 | 0.182 | 0.037 | Calcium-independent phospholipase A2 inhibitor | 0.037 0.015 DBMET01886 0.037 0.015 DBMET01887 | DBMET01887 | |
| 0.041 | 0.206 | 0.079 | Neuropeptide Y antagonist | 0.079 0.06 DBMET01885 | DBMET01885 | |
| 0.005 | 0.182 | 0.145 | Leukotriene A4 hydrolase inhibitor | 0.145 0.005 DBMET01886 0.145 0.005 DBMET01887 | DBMET01887 | |
| 0.159 | 0.341 | 0.282 | Apoptosis agonist | 0.282 0.186 DBMET01886 0.255 0.208 DBMET01885 0.282 0.186 DBMET01887 | DBMET01887 | |
| 0.047 | 0.231 | 0.11 | DNA polymerase I inhibitor | 0.11 0.076 DBMET01886 0.11 0.076 DBMET01887 | DBMET01887 | |
| 0.027 | 0.219 | 0.05 | Vanilloid 2 antagonist | 0.05 0.041 DBMET01886 0.05 0.041 DBMET01887 | DBMET01887 | |
| 0.011 | 0.215 | 0.395 | Glycine transporter 2 inhibitor | 0.395 0.003 DBMET01886 0.395 0.003 DBMET01887 | DBMET01887 | |
| 0.007 | 0.222 | 0.244 | Antimetabolite | 0.244 0.007 DBMET01886 0.061 0.025 DBMET01885 0.244 0.007 DBMET01887 | DBMET01887 | |
| 0.044 | 0.269 | 0.138 | Beta amyloid protein antagonist | 0.138 0.05 DBMET01886 0.138 0.05 DBMET01887 | DBMET01887 | |
| 0.021 | 0.277 | 0.074 | Botulinum neurotoxin type A inhibitor | 0.074 0.021 DBMET01885 | DBMET01885 | |
| 0.017 | 0.278 | 0.055 | Glutamate (mGluR8) antagonist | 0.055 0.007 DBMET01886 0.055 0.007 DBMET01887 | DBMET01887 | |
| 0.006 | 0.275 | 0.043 | AMPA 2 receptor antagonist | 0.043 0.013 DBMET01886 0.043 0.013 DBMET01887 | DBMET01887 | |
| 0.003 | 0.279 | 0.11 | Arginase inhibitor | 0.11 0.003 DBMET01886 0.11 0.003 DBMET01887 | DBMET01887 | |
| 0.029 | 0.307 | 0.059 | Adenine nucleotide translocase inhibitor | 0.059 0.03 DBMET01886 0.059 0.03 DBMET01887 | DBMET01887 | |
| 0.015 | 0.295 | 0.306 | Catalase inhibitor | 0.306 0.006 DBMET01886 0.133 0.03 DBMET01885 0.306 0.006 DBMET01887 | DBMET01887 | |
| 0.03 | 0.357 | 0.127 | Protein-tyrosine phosphatase inhibitor | 0.127 0.104 DBMET01886 0.127 0.104 DBMET01887 | DBMET01887 | |
| 0.085 | 0.412 | 0.464 | Vasodilator, peripheral | 0.464 0.037 DBMET01886 0.428 0.047 DBMET01885 0.464 0.037 DBMET01887 | DBMET01887 | |
| 0.006 | 0.337 | 0.093 | Matrix metalloproteinase 1 inhibitor | 0.093 0.015 DBMET01885 | DBMET01885 | |
| 0.069 | 0.42 | 0.142 | Lipocortins synthesis antagonist | 0.142 0.117 DBMET01886 0.142 0.117 DBMET01887 | DBMET01887 | |
| 0.004 | 0.367 | 0.017 | Kainate receptor 3 antagonist | 0.017 0.012 DBMET01886 0.017 0.012 DBMET01887 | DBMET01887 | |
| 0.02 | 0.387 | 0.297 | Mediator release inhibitor | 0.297 0.007 DBMET01886 0.094 0.077 DBMET01885 0.297 0.007 DBMET01887 | DBMET01887 | |
| 0.004 | 0.371 | 0.131 | Lysine carboxypeptidase inhibitor | 0.131 0.003 DBMET01886 0.131 0.003 DBMET01887 | DBMET01887 | |
| 0.02 | 0.414 | 0.123 | CD45 antagonist | 0.123 0.007 DBMET01886 0.119 0.007 DBMET01885 0.123 0.007 DBMET01887 | DBMET01887 | |
| 0.005 | 0.466 | 0.067 | NMDA 2C receptor antagonist | 0.067 0.037 DBMET01886 0.064 0.04 DBMET01885 0.067 0.037 DBMET01887 | DBMET01887 | |
| 0.044 | 0.505 | 0.243 | Transcription factor STAT3 inhibitor | 0.243 0.089 DBMET01886 0.195 0.14 DBMET01885 0.243 0.089 DBMET01887 | DBMET01887 | |
| 0.009 | 0.478 | 0.263 | Histidine decarboxylase inhibitor | 0.263 0.008 DBMET01886 0.263 0.008 DBMET01887 | DBMET01887 | |
| 0.001 | 0.483 | 0.018 | CXC chemokine 4 receptor agonist | 0.018 0.007 DBMET01886 0.018 0.007 DBMET01887 | DBMET01887 | |
| 0.002 | 0.484 | 0.106 | AMPA 1 receptor antagonist | 0.106 0.005 DBMET01886 0.106 0.005 DBMET01887 | DBMET01887 | |
| 0.024 | 0.525 | 0.175 | Hypolipemic | 0.175 0.114 DBMET01886 0.175 0.114 DBMET01887 | DBMET01887 | |
| 0.007 | 0.516 | 0.051 | HCV NS3/NS4A protease inhibitor | 0.051 0.031 DBMET01886 0.051 0.031 DBMET01887 | DBMET01887 | |
| 0.042 | 0.553 | 0.577 | Vanilloid 1 agonist | 0.577 0.002 DBMET01886 0.138 0.053 DBMET01885 0.577 0.002 DBMET01887 | DBMET01887 | |
| 0.003 | 0.544 | 0.039 | Sirtuin 2 inhibitor | 0.039 0.018 DBMET01886 0.039 0.018 DBMET01887 | DBMET01887 | |
| 0.008 | 0.551 | 0.033 | Thrombin receptor antagonist | 0.033 0.015 DBMET01885 | DBMET01885 | |
| 0.02 | 0.571 | 0.116 | Thioredoxin inhibitor | 0.116 0.034 DBMET01886 0.116 0.034 DBMET01887 | DBMET01887 | |
| 0.005 | 0.591 | 0.058 | Factor XIIIa inhibitor | 0.058 0.012 DBMET01886 0.058 0.012 DBMET01887 | DBMET01887 | |
| 0.01 | 0.601 | 0.385 | Phospholipase A2 inhibitor | 0.385 0.005 DBMET01886 0.187 0.05 DBMET01885 0.385 0.005 DBMET01887 | DBMET01887 | |
| 0.008 | 0.611 | 0.2 | Aminopeptidase I inhibitor | 0.2 0.007 DBMET01886 0.2 0.007 DBMET01887 | DBMET01887 | |
| 0.009 | 0.615 | 0.266 | Interferon agonist | 0.266 0.004 DBMET01886 0.266 0.004 DBMET01887 | DBMET01887 | |
| 0.005 | 0.629 | 0.043 | Plasmepsin II inhibitor | 0.043 0.026 DBMET01885 | DBMET01885 | |
| 0.027 | 0.673 | 0.25 | Antibacterial | 0.25 0.177 DBMET01886 0.25 0.177 DBMET01887 | DBMET01887 | |
| 0.001 | 0.648 | 0.063 | Ileal bile acid transport inhibitor | 0.063 0.003 DBMET01886 0.063 0.003 DBMET01887 | DBMET01887 | |
| 0.016 | 0.665 | 0.162 | Antibacterial (Helicobacter pylori) | 0.162 0.037 DBMET01886 0.162 0.037 DBMET01887 | DBMET01887 | |
| 0.003 | 0.701 | 0.085 | NMDA 2A receptor antagonist | 0.085 0.018 DBMET01886 0.085 0.018 DBMET01887 | DBMET01887 | |
| 0.009 | 0.709 | 0.179 | Caspase 3 inhibitor | 0.179 0.014 DBMET01886 0.113 0.071 DBMET01885 0.179 0.014 DBMET01887 | DBMET01887 | |
| 0.015 | 0.735 | 0.206 | Adenylate cyclase stimulant | 0.206 0.011 DBMET01886 0.206 0.011 DBMET01887 | DBMET01887 | |
| 0.004 | 0.73 | 0.408 | Alkylator | 0.408 0.007 DBMET01886 0.408 0.007 DBMET01887 | DBMET01887 | |
| 0.003 | 0.732 | 0.021 | Caspase 8 inhibitor | 0.021 0.011 DBMET01886 0.021 0.011 DBMET01887 | DBMET01887 | |
| 0.003 | 0.747 | 0.205 | Argininosuccinate synthase inhibitor | 0.205 0.007 DBMET01886 0.205 0.007 DBMET01887 | DBMET01887 | |
| 0.016 | 0.766 | 0.198 | Transcription factor STAT inhibitor | 0.198 0.141 DBMET01886 0.198 0.141 DBMET01887 | DBMET01887 | |
| 0.007 | 0.759 | 0.151 | Interleukin 1 beta converting enzyme inhibitor | 0.151 0.017 DBMET01886 0.122 0.033 DBMET01885 0.151 0.017 DBMET01887 | DBMET01887 | |
| 0.006 | 0.762 | 0.146 | Falcipain 3 inhibitor | 0.146 0.038 DBMET01885 | DBMET01885 | |
| 0.017 | 0.772 | 0.241 | Photosensitizer | 0.241 0.007 DBMET01886 0.241 0.007 DBMET01887 | DBMET01887 | |
| 0.005 | 0.769 | 0.469 | Calpain 2 inhibitor | 0.389 0.067 DBMET01886 0.469 0.033 DBMET01885 0.389 0.067 DBMET01887 | DBMET01885 | |
| 0.02 | 0.791 | 0.282 | Gastrin inhibitor | 0.272 0.056 DBMET01886 0.282 0.047 DBMET01885 0.272 0.056 DBMET01887 | DBMET01885 | |
| 0.005 | 0.796 | 0.164 | Interferon inducer | 0.164 0.004 DBMET01886 0.164 0.004 DBMET01887 | DBMET01887 | |
| 0.001 | 0.797 | 0.054 | Carbonic anhydrase IV inhibitor | 0.054 0.022 DBMET01886 0.054 0.022 DBMET01887 | DBMET01887 | |
| 0.014 | 0.825 | 0.536 | Phospholipase C inhibitor | 0.536 0.005 DBMET01886 0.536 0.005 DBMET01887 | DBMET01887 | |
| 0.017 | 0.837 | 0.278 | Superoxide dismutase inhibitor | 0.278 0.059 DBMET01886 0.278 0.059 DBMET01887 | DBMET01887 | |
| 0.003 | 0.824 | 0.113 | Epithelial sodium channel blocker | 0.113 0.005 DBMET01886 0.113 0.005 DBMET01887 | DBMET01887 | |
| 0.029 | 0.884 | 0.139 | Heat shock protein 70 antagonist | 0.139 0.08 DBMET01886 0.139 0.08 DBMET01887 | DBMET01887 | |
| 0.002 | 0.861 | 0.03 | Peptide deformylase inhibitor | 0.03 0.021 DBMET01886 0.03 0.021 DBMET01887 | DBMET01887 | |
| 0 | 0.868 | 0.026 | Integrin alphaVbeta5 antagonist | 0.026 0.004 DBMET01886 0.026 0.004 DBMET01887 | DBMET01887 | |
| 0.004 | 0.882 | 0.189 | Spasmolytic | 0.189 0.129 DBMET01886 0.189 0.129 DBMET01887 | DBMET01887 | |
| 0.002 | 0.884 | 0.046 | Prolyl endopeptidase inhibitor | 0.046 0.042 DBMET01886 0.046 0.042 DBMET01887 | DBMET01887 | |
| 0.003 | 0.886 | 0.189 | Nitric-oxide synthase inhibitor | 0.189 0.011 DBMET01886 0.189 0.011 DBMET01887 | DBMET01887 | |
| 0.005 | 0.9 | 0.375 | Transcription factor NF kappa B inhibitor | 0.375 0.069 DBMET01886 0.375 0.069 DBMET01887 | DBMET01887 | |
| 0.004 | 0.914 | 0.147 | Ornithine decarboxylase inhibitor | 0.147 0.012 DBMET01886 0.147 0.012 DBMET01887 | DBMET01887 | |
| 0.005 | 0.918 | 0.312 | DNA synthesis inhibitor | 0.312 0.04 DBMET01886 0.312 0.04 DBMET01887 | DBMET01887 | |
| 0.001 | 0.914 | 0.349 | Glutamate decarboxylase inhibitor | 0.349 0.003 DBMET01886 0.349 0.003 DBMET01887 | DBMET01887 | |
| 0.005 | 0.922 | 0.145 | Antipruritic | 0.145 0.1 DBMET01886 0.145 0.1 DBMET01887 | DBMET01887 | |
| 0.003 | 0.929 | 0.045 | Adenosine deaminase inhibitor | 0.045 0.035 DBMET01886 0.045 0.035 DBMET01887 | DBMET01887 | |
| 0.003 | 0.93 | 0.09 | Gastric antisecretory | 0.09 0.078 DBMET01886 0.09 0.078 DBMET01887 | DBMET01887 | |
| 0.005 | 0.934 | 0.46 | Glutamate dehydrogenase inhibitor | 0.46 0.003 DBMET01886 0.46 0.003 DBMET01887 | DBMET01887 | |
| 0.006 | 0.943 | 0.274 | Cyclooxygenase 3 inhibitor | 0.274 0.007 DBMET01886 0.274 0.007 DBMET01887 | DBMET01887 | |
| 0.002 | 0.939 | 0.087 | Beta adrenoreceptor antagonist | 0.087 0.023 DBMET01886 0.087 0.023 DBMET01887 | DBMET01887 | |
| 0.009 | 0.947 | 0.289 | Interferon gamma antagonist | 0.289 0.022 DBMET01886 0.289 0.022 DBMET01887 | DBMET01887 | |
| 0.002 | 0.941 | 0.139 | Inducible nitric-oxide synthase inhibitor | 0.139 0.019 DBMET01886 0.139 0.019 DBMET01887 | DBMET01887 | |
| 0.006 | 0.947 | 0.343 | Vasodilator, coronary | 0.343 0.058 DBMET01886 0.343 0.058 DBMET01887 | DBMET01887 | |
| 0.013 | 0.954 | 0.513 | Histamine release inhibitor | 0.513 0.024 DBMET01886 0.513 0.024 DBMET01887 | DBMET01887 | |
| 0.002 | 0.948 | 0.145 | Expectorant | 0.145 0.037 DBMET01886 0.145 0.037 DBMET01887 | DBMET01887 | |
| 0.005 | 0.952 | 0.387 | Peroxidase inhibitor | 0.387 0.022 DBMET01886 0.387 0.022 DBMET01887 | DBMET01887 | |
| 0.004 | 0.955 | 0.183 | Cell wall synthesis inhibitor | 0.183 0.038 DBMET01886 0.183 0.038 DBMET01887 | DBMET01887 | |
| 0.001 | 0.952 | 0.087 | Monophenol monooxygenase inhibitor | 0.087 0.086 DBMET01886 0.087 0.086 DBMET01887 | DBMET01887 | |
| 0.004 | 0.956 | 0.304 | DNA damaging | 0.304 0.055 DBMET01886 0.304 0.055 DBMET01887 | DBMET01887 | |
| 0.002 | 0.956 | 0.157 | Mucolytic | 0.157 0.029 DBMET01886 0.157 0.029 DBMET01887 | DBMET01887 | |
| 0.001 | 0.96 | 0.052 | Beta 2 adrenoreceptor antagonist | 0.052 0.034 DBMET01886 0.052 0.034 DBMET01887 | DBMET01887 | |
| 0 | 0.961 | 0.052 | AMPA 3 receptor antagonist | 0.052 0.008 DBMET01886 0.052 0.008 DBMET01887 | DBMET01887 | |
| 0.001 | 0.962 | 0.074 | Phenylalanine 4-hydroxylase inhibitor | 0.074 0.043 DBMET01886 0.074 0.043 DBMET01887 | DBMET01887 | |
| 0.001 | 0.962 | 0.047 | Sphingosine 1-phosphate receptor 1 agonist | 0.047 0.023 DBMET01886 0.047 0.023 DBMET01887 | DBMET01887 | |
| 0.002 | 0.97 | 0.168 | Anesthetic general | 0.168 0.096 DBMET01886 0.168 0.096 DBMET01887 | DBMET01887 | |
| 0.001 | 0.969 | 0.067 | AMPA 4 receptor antagonist | 0.067 0.008 DBMET01886 0.067 0.008 DBMET01887 | DBMET01887 | |
| 0.001 | 0.969 | 0.047 | Phosphorylase inhibitor | 0.047 0.032 DBMET01886 0.047 0.032 DBMET01887 | DBMET01887 | |
| 0.001 | 0.971 | 0.05 | Sphingosine 1-phosphate receptor agonist | 0.05 0.025 DBMET01886 0.05 0.025 DBMET01887 | DBMET01887 | |
| 0 | 0.971 | 0.095 | Kainate receptor antagonist | 0.095 0.008 DBMET01886 0.095 0.008 DBMET01887 | DBMET01887 | |
| 0.001 | 0.972 | 0.062 | Beta 2 adrenoreceptor agonist | 0.062 0.04 DBMET01886 0.062 0.04 DBMET01887 | DBMET01887 | |
| 0.001 | 0.976 | 0.084 | Alcohol dehydrogenase inhibitor | 0.084 0.074 DBMET01886 0.084 0.074 DBMET01887 | DBMET01887 | |
| 0.001 | 0.976 | 0.064 | Thromboxane synthase inhibitor | 0.064 0.023 DBMET01886 0.064 0.023 DBMET01887 | DBMET01887 | |
| 0.001 | 0.976 | 0.12 | Sphingosine 1-phosphate receptor 4 agonist | 0.12 0.017 DBMET01886 0.12 0.017 DBMET01887 | DBMET01887 | |
| 0.001 | 0.978 | 0.08 | Membrane dipeptidase inhibitor | 0.08 0.005 DBMET01886 0.08 0.005 DBMET01887 | DBMET01887 | |
| 0 | 0.977 | 0.08 | Thymidylate synthase inhibitor | 0.08 0.008 DBMET01886 0.08 0.008 DBMET01887 | DBMET01887 | |
| 0.001 | 0.979 | 0.12 | Lysophosphatidic acid 3 receptor antagonist | 0.12 0.004 DBMET01886 0.12 0.004 DBMET01887 | DBMET01887 | |
| 0.003 | 0.983 | 0.335 | Adenylate kinase inhibitor | 0.335 0.005 DBMET01886 0.335 0.005 DBMET01887 | DBMET01887 | |
| 0.001 | 0.985 | 0.123 | Anesthetic local | 0.123 0.064 DBMET01886 0.123 0.064 DBMET01887 | DBMET01887 | |
| 0.001 | 0.985 | 0.247 | NMDA receptor agonist | 0.247 0.004 DBMET01886 0.247 0.004 DBMET01887 | DBMET01887 | |
| 0.001 | 0.986 | 0.07 | AICAR transformylase inhibitor | 0.07 0.01 DBMET01886 0.07 0.01 DBMET01887 | DBMET01887 | |
| 0.001 | 0.986 | 0.051 | Cytokine production stimulant | 0.051 0.027 DBMET01886 0.051 0.027 DBMET01887 | DBMET01887 | |
| 0 | 0.986 | 0.052 | Lysophosphatidic acid receptor 1 agonist | 0.052 0.004 DBMET01886 0.052 0.004 DBMET01887 | DBMET01887 | |
| 0 | 0.987 | 0.018 | Antibiotic Anthracycline-like | 0.018 0.016 DBMET01886 0.018 0.016 DBMET01887 | DBMET01887 | |
| 0 | 0.987 | 0.086 | Kainate receptor 2 antagonist | 0.086 0.005 DBMET01886 0.086 0.005 DBMET01887 | DBMET01887 | |
| 0.004 | 0.99 | 0.285 | Tyrosine 3 hydroxylase inhibitor | 0.285 0.041 DBMET01886 0.285 0.041 DBMET01887 | DBMET01887 | |
| 0 | 0.988 | 0.05 | Thromboxane antagonist | 0.05 0.042 DBMET01886 0.05 0.042 DBMET01887 | DBMET01887 | |
| 0.001 | 0.989 | 0.121 | Aldehyde dehydrogenase inhibitor | 0.121 0.069 DBMET01886 0.121 0.069 DBMET01887 | DBMET01887 | |
| 0 | 0.988 | 0.054 | Thromboxane A2 antagonist | 0.054 0.033 DBMET01886 0.054 0.033 DBMET01887 | DBMET01887 | |
| 0.002 | 0.99 | 0.09 | Anabolic | 0.09 0.079 DBMET01886 0.09 0.079 DBMET01887 | DBMET01887 | |
| 0 | 0.989 | 0.085 | Calcium-sensing receptor agonist | 0.085 0.004 DBMET01886 0.085 0.004 DBMET01887 | DBMET01887 | |
| 0.002 | 0.992 | 0.343 | DNA methylase inhibitor | 0.343 0.018 DBMET01886 0.343 0.018 DBMET01887 | DBMET01887 | |
| 0.002 | 0.992 | 0.336 | Cholesterol antagonist | 0.336 0.071 DBMET01886 0.336 0.071 DBMET01887 | DBMET01887 | |
| 0.001 | 0.992 | 0.305 | DNA methyltransferase I inhibitor | 0.305 0.024 DBMET01886 0.305 0.024 DBMET01887 | DBMET01887 | |
| 0.001 | 0.992 | 0.285 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.285 0.007 DBMET01886 0.285 0.007 DBMET01887 | DBMET01887 | |
| 0 | 0.991 | 0.069 | Mannosidase inhibitor | 0.069 0.012 DBMET01886 0.069 0.012 DBMET01887 | DBMET01887 | |
| 0 | 0.991 | 0.213 | Phosphofructokinase-1 inhibitor | 0.213 0.01 DBMET01886 0.213 0.01 DBMET01887 | DBMET01887 | |
| 0 | 0.992 | 0.068 | Epoxide hydrolase inhibitor | 0.068 0.055 DBMET01886 0.068 0.055 DBMET01887 | DBMET01887 | |
| 0 | 0.993 | 0.069 | Glutamate (mGluR4) antagonist | 0.069 0.01 DBMET01886 0.069 0.01 DBMET01887 | DBMET01887 | |
| 0 | 0.993 | 0.197 | GABA C receptor agonist | 0.197 0.021 DBMET01886 0.197 0.021 DBMET01887 | DBMET01887 | |
| 0 | 0.993 | 0.231 | Carbamoyl phosphate synthetase inhibitor | 0.231 0.006 DBMET01886 0.231 0.006 DBMET01887 | DBMET01887 | |
| 0 | 0.993 | 0.038 | Glutamate (mGluR3) antagonist | 0.038 0.023 DBMET01886 0.038 0.023 DBMET01887 | DBMET01887 | |
| 0 | 0.995 | 0.098 | Phospholipase D inhibitor | 0.098 0.016 DBMET01886 0.098 0.016 DBMET01887 | DBMET01887 | |
| 0 | 0.995 | 0.031 | Fumarate hydratase inhibitor | 0.031 0.027 DBMET01886 0.031 0.027 DBMET01887 | DBMET01887 | |
| 0 | 0.996 | 0.038 | Glutamate (mGluR3) agonist | 0.038 0.013 DBMET01886 0.038 0.013 DBMET01887 | DBMET01887 | |
| 0 | 0.996 | 0.027 | Glutamate (mGluR1) agonist | 0.027 0.013 DBMET01886 0.027 0.013 DBMET01887 | DBMET01887 | |
| 0 | 0.996 | 0.017 | Methylmalonyl-CoA mutase inhibitor | 0.017 0.016 DBMET01886 0.017 0.016 DBMET01887 | DBMET01887 | |
| 0 | 0.996 | 0.075 | Alpha-mannosidase inhibitor | 0.075 0.013 DBMET01886 0.075 0.013 DBMET01887 | DBMET01887 | |
| 0 | 0.996 | 0.19 | Succinate dehydrogenase inhibitor | 0.19 0.057 DBMET01886 0.19 0.057 DBMET01887 | DBMET01887 | |
| 0 | 0.997 | 0.094 | Glutamate (mGluR6) antagonist | 0.094 0.013 DBMET01886 0.094 0.013 DBMET01887 | DBMET01887 | |
| 0 | 0.997 | 0.078 | Acyl-CoA dehydrogenase inhibitor | 0.078 0.023 DBMET01886 0.078 0.023 DBMET01887 | DBMET01887 | |
| 0 | 0.997 | 0.016 | Carbonic anhydrase VIII inhibitor | 0.016 0.012 DBMET01886 0.016 0.012 DBMET01887 | DBMET01887 | |
| 0 | 0.997 | 0.016 | Carbonic anhydrase X inhibitor | 0.016 0.012 DBMET01886 0.016 0.012 DBMET01887 | DBMET01887 | |
| 0 | 0.998 | 0.085 | GABA aminotransferase inhibitor | 0.085 0.041 DBMET01886 0.085 0.041 DBMET01887 | DBMET01887 | |
| 0.001 | 0.999 | 0.212 | 5 Hydroxytryptamine uptake stimulant | 0.212 0.131 DBMET01886 0.212 0.131 DBMET01887 | DBMET01887 | |
| 0 | 0.998 | 0.048 | Glutamate (mGluR8) agonist | 0.048 0.013 DBMET01886 0.048 0.013 DBMET01887 | DBMET01887 | |
| 0 | 0.998 | 0.087 | Triose-phosphate isomerase inhibitor | 0.087 0.064 DBMET01886 0.087 0.064 DBMET01887 | DBMET01887 | |
| 0 | 0.998 | 0.02 | Glutamate (mGluR1a) agonist | 0.02 0.019 DBMET01886 0.02 0.019 DBMET01887 | DBMET01887 | |
| 0 | 0.999 | 0.038 | Kainate receptor agonist | 0.038 0.036 DBMET01886 0.038 0.036 DBMET01887 | DBMET01887 | |
| 0 | 0.999 | 0.17 | Alpha-N-acetylglucosaminidase inhibitor | 0.17 0.045 DBMET01886 0.17 0.045 DBMET01887 | DBMET01887 | |
| 0 | 0.999 | 0.09 | Glutamate (mGluR7) agonist | 0.09 0.085 DBMET01886 0.09 0.085 DBMET01887 | DBMET01887 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |